ArticleOncology reports2020

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer.

Tanzeel Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.